Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Certified by Founder
Lodge
I2BF Global Ventures
investor
United States
- New York, NY
- 13/12/2022
- Series A
- $21,000,000
I2BF Global Ventures is a New York based venture capital group focused on early stage technology investments with $400 million under management. I2BF’s portfolio includes over 30 companies working in cleantech, biotechnology, materials science, IT and space technology sectors.
- Industry Venture Capital and Private Equity Principals
- Website https://www.i2bf.com/
- LinkedIn https://www.linkedin.com/company/i2bf-global-ventures/
Related People
Ilya GolubovichFounder
United States -
New York, NY
Ilya Golubovich is the founding and managing partner of I2BF Global Ventures, an international venture capital group focused on early stage technology investments with over $500 million under management. I2BF’s portfolio includes over 100 companies working in frontier tech, digital transformation and future of content industries.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)